HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$22.75
Day range
$21.37 - $22.88
Year range
$14.59 - $35.84
Market cap
621.36M USD
Avg Volume
636.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 86.19M | -0.94% |
Operating expense | 72.81M | 7.92% |
Net income | 4.52M | -49.29% |
Net profit margin | 5.25 | -48.78% |
Earnings per share | 0.15 | -51.61% |
EBITDA | -837.00K | -110.01% |
Effective tax rate | 3,262.94% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 275.93M | 6.25% |
Total assets | 544.73M | 11.78% |
Total liabilities | 89.35M | 40.89% |
Total equity | 455.38M | — |
Shares outstanding | 29.01M | — |
Price to book | 1.45 | — |
Return on assets | -2.03% | — |
Return on capital | -2.22% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 4.52M | -49.29% |
Cash from operations | 20.82M | -13.24% |
Cash from investing | -28.38M | -32.50% |
Cash from financing | 101.00K | 140.48% |
Net change in cash | -7.46M | -384.25% |
Free cash flow | 16.84M | -4.17% |
About
Founded
2007
Headquarters
Website
Employees
798